T cell responses in patients with COVID-19

Zeyu Chen; E John Wherry

doi:10.1038/s41577-020-0402-6

T cell responses in patients with COVID-19

Nat Rev Immunol. 2020 Sep;20(9):529-536. doi: 10.1038/s41577-020-0402-6. Epub 2020 Jul 29.

Authors

Zeyu Chen¹, E John Wherry²

Affiliations

¹ Department of Systems Pharmacology and Translational Therapeutics, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Department of Systems Pharmacology and Translational Therapeutics, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.

Abstract

The role of T cells in the resolution or exacerbation of COVID-19, as well as their potential to provide long-term protection from reinfection with SARS-CoV-2, remains debated. Nevertheless, recent studies have highlighted various aspects of T cell responses to SARS-CoV-2 infection that are starting to enable some general concepts to emerge.

Publication types

Review
Research Support, Non-U.S. Gov't

Abstract

Publication types

Grants and funding